Newly emerged hantaviruses replicate primarily in the pulmonary endothelium, cause acute platelet loss, and result in hantavirus pulmonary syndrome (HPS). We now report that specific integrins expressed on platelets and endothelial cells permit the cellular entry of HPS-associated hantaviruses. Infection with HPS-associated hantaviruses, NY-1 and Sin Nombre virus (SNV), is inhibited by antibodies to beta(3) integrins and by the beta(3)-integrin ligand, vitronectin. In contrast, infection with the nonpathogenic (no associated human disease) Prospect Hill virus was inhibited by fibronectin and beta(1)-specific antibodies but not by beta(3)-specific antibodies or vitronectin. Transfection with recombinant alpha(IIIb)beta(3) or alpha(v) beta(3) integrins rendered cells permissive to NY-1 and SNV but not Prospect Hill virus infection, indicating that alpha(IIb)beta(3) and alpha(v) beta(3) integrins mediate the entry of NY-land SNV hantaviruses. Furthermore, entry;is divalent cation independent, not blocked by arginine-glycine-aspartic acid peptides and still mediated by, ligand-binding defective, alpha(IIb)beta(3)-integrin mutants. Hence, NY-1. and SNV entry is independent of beta(3) integrin binding to physiologic ligands. These findings implicate integrins as cellular receptors for hantaviruses and indicate that hantavirus pathogenicity correlates with integrin usage.